Navigation Links
InspireMD Reports Financial Results for Quarter Ended September 30, 2013
Date:11/11/2013

rantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of the Company's existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of the Company's products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) the Company's limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payers for the Company's products, (viii) the Company's efforts to successfully obtain and maintain intellectual property protection covering its products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) the Company's reliance on single suppliers for certain product components, (xi) the fact that the Company will need to raise additional capital to meet its business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that the Company conducts business in multiple foreign jurisdictions, exposing the Company to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward looking statements is set
'/>"/>
SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... quarter financial results on Tuesday, August 5, 2014, after ... host a live audio webcast immediately following the announcement ... business and financial update and discuss second quarter 2014 ... live audio webcast via the Investors & Media section ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
(Date:7/22/2014)... 2014 Legislation backed by the drugstore ... Pharmacies Act of 2014") championing so-called "any willing ... the availability of lower cost preferred pharmacy networks ... the next 10 years, according to new research ... Care Management Association (PCMA). The drugstore ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... A unique collaborative effort among business leaders and health ... nation for health care has led to more than $12.8 ... days spent in the hospital and nearly 3,600 fewer adverse ... Solutions for Patient Safety initiative, launched in January 2009 ...
... Jan. 18, 2011 WebMD Health Corp. (Nasdaq: ... health information, has launched its Medscape from WebMD ... and tablets.  Medscape Mobile is the premier free ... professionals.  Since its release on the iPhone® and ...
Cached Medicine Technology:Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 2Ohio Business, Health Care Leaders' Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million 3WebMD Launches Medscape for iPad™ and Android™ Devices 2WebMD Launches Medscape for iPad™ and Android™ Devices 3
(Date:7/22/2014)... By Steven Reinberg ... -- Women who are obese during pregnancy may be more ... new review suggests. "We found that, compared with children ... overweight or obese during pregnancy had up to 20 to ... Erick Forno, an assistant professor of pediatrics at Children,s Hospital ...
(Date:7/22/2014)... the University of Utah,s John A. Moran Eye Center, ... Research (ISER) as the recipient of the Houston, Texas-based ... Retina Research., The award recognizes lifetime achievement by a ... the understanding of vitreoretinal diseases or disorders. The award ... Meeting in San Francisco, where Marc will deliver a ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... Ticket Down is a reliable source for cheap Manchester ... MD. There has never been a better time in the ... success of the American national soccer team at the 2014 World ... that fans of the world’s sport will be able to feed ... Champions Cup. The tournament will kick off on July 24 and ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- One of the ... a psychiatric disorder has uncovered 83 new sites on ... The findings, made by an international team of researchers, ... linked to the disorder to 108. Although ... as a test to predict who will or will ...
Breaking Medicine News(10 mins):Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2
... GPRC5A gene, which is under-expressed in human lung cancer cells, ... key to attacking lung cancer in humans, researchers at The ... the Nov. 21 edition of The Journal of the National ... of their GPRC5A genes suppressed developed normally until their second ...
... current laws are too cumbersome , , TUESDAY, Nov. 13 ... in their efforts to protect human research subjects, a ... doctors recently surveyed said that the Health Insurance Portability ... patients, medical information, has hindered research. Only one-quarter felt ...
... Sorting Out the Bitters , Maik Behrens, ... , The story goes that bitter taste receptors ... course, have diverse chemical structures. It has been debated ... whether we need multiple bitter receptors. Bitter taste is ...
... delivery ... technology., CLEVELAND, ... patented, 81 milligram aspirin tablet that,dissolves rapidly in the mouth instead ... of Americans who maintain a,daily aspirin routine and worry about gastrointestinal ...
... Heartburn Alliance Sponsors First Ever Heartburn Awareness Month, ... ... remains a burning problem,for more than 60 million Americans each month(1), ... for heartburn,education by sponsoring the first ever Heartburn Awareness Month. ...
... ... Tennis Champions, CHATHAM, N.J., Nov. 13 The Justin ... Jersey. The event will take place on two dates. On Sunday,December 9, ... tournaments with professional tennis champions. On Thursday,December 13, at 7 PM fans ...
Cached Medicine News:Health News:M. D. Anderson researchers identify tumor-suppressor gene for lung cancer 2Health News:Rules on Patients' Medical Data Hampering Research 2Health News:Rules on Patients' Medical Data Hampering Research 3Health News:News Tips from the Journal of Neuroscience 2Health News:News Tips from the Journal of Neuroscience 3Health News:New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 2Health News:Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 3Health News:The Justin Gimelstob Children's Fund Hosts Tennis Exhibition 2
... is an intracorporeal electrokinetic lithotripter particularly ... VIBROLITH guarantees satisfaction in application to ... gall bladder and salivary gland stones. ... percutaneous applications. Kinetic energy transmitted by ...
Combination Ultrasonic and Pneumatic Urological Lithotriptor. Consists of four sizes of rigid pneumatic probes for use in the kidney, ureter and bladder....
... Multiline offers an ideal combination of ... easy and effective treatment of urinary ... wide range of urological applications. ... images enabling rapid, precise stone localization. ...
... MODULITH SLX is not only one of the ... versatile medical workstation. Apart from being designed for ... in the urinary tract, the MODULITH SLX can ... endourological therapies. It is equally suitable for the ...
Medicine Products: